Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Sperm tells tales of your diet before conception
If you are planning a baby, do not just sermon your wife to eat well but control your diet first. According to a fascinating study, sperm carries key information about what new dads gulped down before the conception.
- Read more about Biomarker of early lung cancer identified
Researchers have identified a biomarker that detects the most common lung cancer in its earliest stage.
- Read more about Dedicated body to take neurointerventions forward in India
In order to bring interventions from various backgrounds under a single umbrella, a group of top neurosurgeons has come together to form India's first dedicated society for therapeutic neurointerventions.
- Read more about CDFD scientists discover protein linked to tuberculosis
Scientists at the Centre for DNA Fingerprinting and Diagnostics (CDFD) have discovered a novel protein which could lead to development of a therapy for tuberculosis.
- Read more about GSK receives European marketing authorisation for Nucala® (mepolizumab) in 31 countries
GlaxoSmithKline announced that the European Commission has granted marketing authorisation for Nucala® (mepolizumab) as an add-on treatment for severe refractory eosinophilic asthma in adult patients. As a result Nucala is now approved for use in the 31 European countries covered by the European Medicines Agency (EMA).
- Read more about Boehringer Ingelheim and MD Anderson Cancer Center join forces to discover new treatment approaches for pancreatic cancer
Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced a collaboration focused on developing innovative medicines for pancreatic ductal adenocarcinoma (PDAC). The new collaboration combines MD Anderson’s unique understanding of potential drivers of PDAC with Boehringer Ingelheim’s experience in drug discovery and development.
- Read more about Greatbatch Receives FDA Approval of Algovita(R) Spinal Cord Stimulation System
Greatbatch, Inc. announced that it has received approval from the United States Food and Drug Administration (FDA) for its Algovita® Spinal Cord Stimulation (SCS) System to treat chronic intractable pain of the trunk and/or limbs.
- Read more about Lilly's phase 3 study shows once-weekly Trulicity is effective as add-on treatment to Sulfonylurea
New data from a completed phase 3 trial show Trulicity (dulaglutide) 1.5 mg plus a sulfonylurea was significantly more effective than a sulfonylurea alone in lowering hemoglobin A1c (A1C) from baseline after 24 weeks of treatment. Trulicity is Eli Lilly and Company's once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes. These data, from the Trulicity AWARD-8 clinical trial, were presented for the first time today at the 2015 International Diabetes Federation (IDF) World Diabetes Congress in Vancouver, Canada.
- Read more about Launch of a first Pharmacovigilance peer network - PV India
TAKE Solutions launched PV India, a unique pharmacovigilance peer network, organized and managed by one of TAKE’s Life Sciences division, Navitas. At the time when the pharma industry is facing business challenges and the government of India citing delayed regulatory approvals as a primary concern, it is imperative for Pharma companies to arrive at solutions to tackle these problems.
- Read more about Quantum Pharma pleased to announce licensing deals in Germany
Quantum Pharma Plc, the growing service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors, is pleased to announce a further three out-licensing deals in Germany, though Lamda (UK) Limited, Lamda Laboratories SA and Lamda Pharmaceuticals SA (collectively ‘Lamda’), part of its Niche Pharmaceutical division. These agreements form part of the core strategy for this division.

[adsense:336x280:8701650588]